⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
Growth Hormone Receptor Signaling in Aging
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-10-01 — Hepatocyte Growth Hormone Receptor Ablation Is Associated With Aging Phenotypes and Hepatic Mitochondrial Dysfunction.: cross-connection with hepatic-ghr-signaling: Tissue-specific (hepatocyte) GHR ablation refines the whole-body GHR-longevity axis: liver-autonomous GH signaling loss produces systemic aging phenotypes, dissociating hepatic from non-hepatic GHR contributions to the lifespan phenotype. (novelty: 3)
- 2026-09-26 — Hepatocyte Growth Hormone Receptor Ablation Is Associated With Aging Phenotypes and Hepatic Mitochondrial Dysfunction: Mouse study: hepatocyte-specific GHR ablation produced aging-associated phenotypes and hepatic mitochondrial dysfunction, localizing part of the GH/IGF-1 aging signal to liver-autonomous GHR loss rather than systemic GH deficiency. [animal-model] (novelty: 3)
Open questions
Related
Contributing findings
Hepatocyte Growth Hormone Receptor Ablation Is Associated With Aging Phenotypes and Hepatic Mitochondrial Dysfunction
26-sep-2026
novelty 3
per-area 3
strengthens